NCT00202020 - Efficacy and Safety Study of Cilostazol to Prevent Reoccurrence of Stroke | Biotech Hunter

Enrollment

720

Participants

Timeline

Start Date

May 31, 2004

Study Completion Date

January 31, 2006

Conditions

Cerebral Infarction

Interventions

DRUG

Cilostazol 200mg/day Oral

DRUG

Aspirin 100mg/day Oral

Trial Locations (12)

1st affiliated hospital, Guangzhou Zhongshan University, Guangzhou

2nd affiliated hospital, Guangzhou medical college, Guangzhou

1st affiliated Jilin University, Changchun

1st affiliated hospital, Xi'an Jiatong University, Xi’an

2nd affiliated hospital, Zhejiang University, Hangzhou

1st affiliated hospital, Peking University, Beijing

3rd affiliated hospital, Peking University, Beijing

General Hospital of Beijing Military Area of PLA, Beijing

Renmin Hospital, Peking University, Beijing

Huashan Hospital Shanghai Fudan University, Shanghai

Renji Hospital, Shanghai 2nd medical university, Shanghai

General Hospital, Tianjin Medical University, Tianjin